BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30467014)

  • 1. Predictive factors of benefit from iodine-125 brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis.
    Lin J; Jiang H; Yang W; Jiang N; Zheng Q; Huang N; Wang X; Li A; Huang J
    Brachytherapy; 2019; 18(2):233-239. PubMed ID: 30467014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
    Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of transcatheter arterial chemoembolization combined with either
    Li Y; Li H; Hu H; Yuan H; Zhao Y
    J Cancer Res Ther; 2020; 16(7):1691-1697. PubMed ID: 33565518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
    Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
    Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brachytherapy with Iodine-125 seeds for treatment of portal vein-branch tumor thrombus in patients with hepatocellular carcinoma.
    Hong D; Zhou Y; Wan X; Su H; Shao H
    BMC Cancer; 2021 Sep; 21(1):1020. PubMed ID: 34521375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of endovascular implantation of a portal vein stent combined with iodine-125 seed-strips followed by transcatheter arterial chemoembolization with sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis.
    Li S; Li L; Li B; Wang W
    Br J Radiol; 2020 Aug; 93(1112):20190279. PubMed ID: 32464068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of CT-Guided Iodine-125 Brachytherapy for Portal Vein Tumor Thrombus in Hepatocellular Carcinoma.
    Qiu Z; Yu C; Qiu X; Li Q; Li J; Chen Z; Chang S; Zhang S; Fan G; Wang S
    Acad Radiol; 2023 Sep; 30 Suppl 1():S53-S60. PubMed ID: 36882354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endovascular implantation of
    Sun H; Zhang M; Liu R; Liu Y; Hou Y; Wu C
    Future Oncol; 2018 May; 14(12):1165-1176. PubMed ID: 29334777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: a prospective study.
    Long J; Zheng JS; Sun B; Lu N
    Hepatol Int; 2016 Jan; 10(1):175-84. PubMed ID: 26742761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of endovascular brachytherapy combined with transarterial chemoembolization for the treatment of hepatocellular carcinoma patients with type III or IV portal vein tumor thrombosis.
    Li L; Cheng N; Huang X; Weng X; Jiao Y; Liu J; Guo W
    World J Surg Oncol; 2022 Feb; 20(1):30. PubMed ID: 35109883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort study.
    Huang M; Lin Q; Wang H; Chen J; Bai M; Wang L; Zhu K; Jiang Z; Guan S; Li Z; Qian J; Li M; Pang P; Shan H
    Eur Radiol; 2016 Oct; 26(10):3428-36. PubMed ID: 26792430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. I
    Li S; Guo JH; Lu J; Wang C; Wu H; Wang H; Zha J; Fan R
    Cancer Radiother; 2021 Jun; 25(4):340-349. PubMed ID: 33455874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus.
    Peng ZW; Guo RP; Zhang YJ; Lin XJ; Chen MS; Lau WY
    Cancer; 2012 Oct; 118(19):4725-36. PubMed ID: 22359112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Irradiation Stent Placement for Malignant Portal Vein Thrombus Combined with Transarterial Chemoembolization for Hepatocellular Carcinoma: A Single-Center Experience.
    Lu J; Guo JH; Zhu HD; Zhu GY; Chen L; Teng GJ
    J Vasc Interv Radiol; 2017 Jun; 28(6):786-794.e3. PubMed ID: 28396192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoembolization as first-line treatment for hepatocellular carcinoma invading segmental portal vein with tumour burden limited to a monosegmental level.
    Hwang H; Kim JH; Ko E; Kim JY; Ko HK; Gwon DI; Shin JH; Kim GH; Chu HH
    Br J Radiol; 2024 May; 97(1157):1038-1043. PubMed ID: 38445658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of transarterial chemoembolization combined with lenvatinib, programmed death-1 inhibitor, and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis.
    Lin LW; Yan LY; Ke K; Yang WZ; Lin JQ; Huang N
    Brachytherapy; 2023; 22(6):858-871. PubMed ID: 37574351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reappraisal of Portal Vein Tumor Thrombosis as a Prognostic Factor for Patients with Hepatocellular Carcinoma.
    Chang Y; Yu SJ; Kim HC; Lee YB; Cho EJ; Lee JH; Kim YJ; Chung JW; Yoon JH
    Gut Liver; 2024 Jan; 18(1):156-164. PubMed ID: 38013475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoembolisation with polyvinyl alcohol for advanced hepatocellular carcinoma with portal vein tumour thrombosis and arterioportal shunts: efficacy and prognostic factors.
    Xiao L; Liu Q; Zhao W; Pang H; Zeng Q; Chen Y; Zhao J; Mei Q; He X
    Clin Radiol; 2018 Dec; 73(12):1056.e17-1056.e22. PubMed ID: 30224186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter arterial chemoembolization combined with radiofrequency ablation can improve survival of patients with hepatocellular carcinoma with portal vein tumour thrombosis: extending the indication for ablation?
    Zheng JS; Long J; Sun B; Lu NN; Fang D; Zhao LY; Du N
    Clin Radiol; 2014 Jun; 69(6):e253-63. PubMed ID: 24581962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.